Melanins are pigments responsible for skin and hair follicles pigmentation in mammals. Melanin biosynthesis or melanogenesis occurs in specialized organelles, called melanosomes, through a cascade of enzymatic reactions using the amino acid tyrosine as the initial substrate. The first two steps in the biosynthetic pathway, hydroxylation of tyrosine to L-3,4-dihydroxyphenylalanine (L-DOPA) and oxidation of L-DOPA to dopaquinone, are catalyzed by tyrosinase, a copper-containing, membrane-bound glycoprotein that is the rate limiting enzyme of the melanin biosynthetic pathway.
Melanins are pigments responsible for skin and hair follicles pigmentation in mammals. Melanin biosynthesis or melanogenesis occurs in specialized organelles, called melanosomes, through a cascade of enzymatic reactions using the amino acid tyrosine as the initial substrate. The first two steps in the biosynthetic pathway, hydroxylation of tyrosine to L-3,4-dihydroxyphenylalanine (L-DOPA) and oxidation of L-DOPA to dopaquinone, are catalyzed by tyrosinase, a copper-containing, membrane-bound glycoprotein that is the rate limiting enzyme of the melanin biosynthetic pathway.
Abnormal melanin production such as observed in melasma, freckles, lentigo senilis, and other forms of melanin hyperpigmentation can be a serious aesthetic problem often causing emotional disturbance. 1, 2) Taking into account the key role of tyrosinase in melanin production, many tyrosinase inhibitors have found application in cosmetics and pharmaceutical products. [3] [4] [5] However, most of them are unsatisfactory due to the weak cosmetic/clinical effects and/or to the various safety concerns. [6] [7] [8] Thus hydroquinone reported to induce inhibitory activity against tyrosinase is considered to be highly cytotoxic and mutagenic to mammals cells. 8) Leaving a door opened for the discovery of new tyrosinase inhibitors many efforts have been made in the search for safe and efficient tyrosinase inhibitors. [8] [9] [10] [11] [12] Phenolic compounds such as cinnamic acid and its derivatives (caffeic acid, ferulic acid), have been reported to act as tyrosinase inhibitors. [13] [14] [15] In a recent study Okombi et al. investigated the effect of amides derived from coupling of caffeic acid, ferulic acid and derivatives with phenylalkylamines (tyramine, dopamine) as inhibitors of tyrosinase. 16) They demonstrated the potency of some derivatives such as the Ncaffeoyltyramine but they did not investigate the effect of other derivatives of p-coumaric acid, cinnamic acid obtained by coupling with other phenylalkylamine or phenylmethylamine derivatives. Besides due to high attrition rate of the previously developed tyrosinase inhibitors when moving from in vitro to in vivo studies, it appears important to find out new tyrosinase inhibitory molecules.
On this basis, we synthetized N-(phenylalkyl)cinnamides derived from the coupling of cinnamic acid or its derivatives with phenylalkylamines and evaluated their potential to inhibit tyrosinase activity.
MATERIALS AND METHODS
Materials L-Tyrosine, mushroom tyrosinase, kojic acid, hydroquinone were purchased from Sigma Chemicals.
Mushroom Tyrosinase Assay Tyrosinase activity was determined spectrophotometrically by the modified dopachrome method using L-tyrosine as a substrate. 17) All compounds were first dissolved in dimethyl sulfoxide (DMSO) or in methanol and reference products were solubilized in water, before being diluted in phosphate-buffered saline (PBS) solution pH 6.8. Mushroom tyrosinase (150 units/ml) was preincubated with compound and PBS in a 96-well microplate at 37°C for 10 min. Then L-tyrosine (0.5 mM) was added and the assay mixture was incubated at 37°C for 15 min. Before and after incubation, the amount of dopachrome produced in the reaction mixture was measured at 490 nm. Kojic acid and hydroquinone were used as positive control. The extent of tyrosinase inhibition by the addition of the different compounds was calculated and expressed as the percentage necessary for 50% inhibition (IC 50 ).
Chemistry Cinnamic acid, p-coumaric acid, 3-hydroxycinnamic acid and caffeic acid (10 mmol) were dissolved in 20 ml of dimethylformamide (DMF) and 1.4 ml (10 mmol) of triethylamine. The resulting solution was cooled in an ice water bath and 10 mmol of phenylalkylamine (Table 1) were added followed by a solution of 10 mmol of benzotriazol-1-yloxy-tris-(dimethylamino)-phosphonium hexafluorophosphate (BOP) in 20 ml of CH 2 Cl 2 . The mixture was stirred at 0°C for 30 min and then at room temperature overnight. CH 2 Cl 2 was removed under reduced pressure and the solution was diluted with 150 ml of water. The products were extracted with ethyl acetate. The extract was washed successively with 1 N HCl, water, 1 M NaHCO 3 and water, dried over MgSO 4 , filtered and evaporated. The residue was purified on a silica gel column (eluent: ethyl acetate/petroleum ether). Yields were between 55 and 85%. Increased production and accumulation of melanin lead to hyperpigmentation disorders. Several inhibitors of tyrosinase, the key enzyme in melanin synthesis have been developed but exhibited lack of efficiency or some adverse side effects. Therefore, it appears very important to find new agents that will be able to promote inhibition of tyrosinase and pigmentation. In this study, some phenylalkylcinnamide molecules were synthesized and evaluated for their ability to act as tyrosinase inhibitors. Compounds 2 (IC 50 ‫30.0؍‬ mM) and 12 (IC 50 ‫820.0؍‬ mM) showed strong tyrosinase inhibitory potential comparable to standard hydroquinone (IC 50 ‫730.0؍‬ mM). Taken together, compounds 2 and 12 can be considered as good candidates for further investigations to evaluate their effect on the inhibition of melanin synthesis and skin pigmentation.
RESULTS AND DISCUSSION
As shown in Table 1 , 4-hydroxycinnamic acid (p-coumaric acid), but not 3-hydroxycinnamic acid, had a better inhibitory effect on tyrosinase activity in comparison to cinnamic acid but remained less potent than kojic acid or hydroquinone. Moreover 3,4-dihydroxycinnamic acid (caffeic acid) inhibited tyrosinase activity as potently as 4-hydroxycinnamic acid. These observations indicate that hydroxylation at para position on phenyl ring is important for the inhibitory activity against tyrosinase while hydroxylation at meta position does not improve activity of cinnamic acid. Masamoto et al. also reported an inhibition of tyrosinase activity with these cinnamic acid derivatives. 14) However, in their study, 3,4-dihydroxycinnamic acid was a weaker inhibitor of tyrosinase compared to p-coumaric acid and 3-hydroxycinnamic acid. This discrepancy could be explained by difference in the protocol employed to assess tyrosinase activity. Indeed, we used L-tyrosine as substrate thereby measuring both tyrosine hydroxylase and DOPA oxidase activities of tyrosinase. In contrast, Masamoto et al. used L-DOPA that only allows DOPA oxidase activity evaluation.
N-(Phenylalkyl)cinnamides were synthesized by coupling of cinnamic acid derivatives with phenylethylamine or phenylmethylamine in DMF (dimethylformamide) in the presence of triethylamine and BOP (benzotriazol-1-yloxytris-(dimethylamino)-phosphonium hexafluorophosphate) as a coupling agent affording a variety of compounds (1-19; Chart 1) with good yields. Then all these synthetized compounds were assessed on the activity of mushroom tyrosinase (Table 1) .
Among phenylethyl cinnamide, p-coumaric derivative (R 1 ϭOH, compound 2, IC 50 ϭ0.03 mM), where the phenyl ring of the phenylethyl part was unsubstituted, exhibited an inhibition of tyrosinase activity higher than the unsubstituted compound 1. This result indicates that the hydroxylation at the R 1 position of the cinnamic moiety is important for the tyrosinase inhibition. Furthermore, compound 2 showed an inhibitory activity similar to hydroquinone and a two fold higher effect compared to kojic acid. On the other hand, the caffeic acid derivative (R 1 and R 2 ϭOH, compound 3), with the phenyl ring of the phenylethyl part unsubstituted, lost its inhibitory potential against tyrosinase activity compared to compound 1 or to caffeic acid itself (IC 50 ϭ0.4 mM). However, the introduction of an hydroxyl residue in the para position of the phenylethyl part (R 3 ϭOH, compound 4; IC 50 ϭ0.25 mM ) led to a tyrosinase inhibitory activity higher than that obtained with compound 3 but lower than tyrosinase inhibition induced by compound 2. Finally, no inhibition of tyrosinase activity was observed when caffeic acid derivative was associated with dopamine (R 1 , R 2 , R 3 and R 4 ϭOH, compound 5).
In the same way, a methoxy substitution at R 1 position (compound 6) abolished the ability to inhibit tyrosinase activity compared to compound 2. In contrast, a methoxy substitution at R 3 and R 4 positions of the caffeic acid derivative 7 (IC 50 ϭ0.6 mM), showed potent inhibition of the enzyme tyrosinase as compared with compound 5.
It is well known that halogens can impose certain molecular conformation or influence the potency of a product due to their steric and/or electronic effects. These latter ascribed to electron attracting properties of halogens are generally maxi- mal for chlorine and bromine and differ from hydroxyl and methoxy donors groups. These characteristics prompted us to first evaluate presence of chloro group on the aromatic ring. However substitution of the R 3 position with an halogen (Cl) group (compound 9) did not improve any inhibitory potency against tyrosinase activity compared to compound 2. Two other compounds with a chlorine on the aromatic ring at the R 3 position or R 1 and R 3 positions exhibited no activity (compounds 8 and 10).
Besides, inhibitory efficacy of phenylmethylamide derivatives was similar to that obtained with phenylethylamide derivatives, notably for compounds 2 and 12 (IC 50 values were 0.03 mM and 0.028 mM, respectively). In this phenylmethylamide set, compounds 16 and 11 were found inactive. When the R 5 position was substituted with -Me group the resulting compounds 18 and 19 respectively did not show any improvement.
Therefore, these results led us to draw several interpretations. Among the p-coumaric derivatives (compounds 2, 9, 12) only compounds 2 and 12 demonstrate a better inhibitory efficacy than p-methoxy, catechol or cinnamic derivatives. The carbon chain length (one carbon vs. two carbons) improves only the efficacy of caffeic acid derivatives (compounds 13 and 15 vs. compounds 3 and 5). Moreover, the disubstitution on the aromatic ring of the phenylethylamide part abrogates its inhibitory activity (compound 4 vs. 5) but does not affect that of the phenylmethylamide derivatives equivalents (compound 14 vs. 15). Numerous phenols and catechols are known to be substrates for tyrosinase. Indeed pcoumaric acid was already shown to act as substrate analogue of L-tyrosine and to inhibit the monophenolase activity of the enzyme through a competitive mechanism. 18, 19) These papers clearly indicated that the tyrosinase inhibition mechanism was connected with the 4-hydroxy group which could compete with L-tyrosine for binding to the active site of the enzyme. 18, 20) So, the activity of p-coumaric acid could explain the potency of p-coumaric derivatives (2, 12) compared to the other derivatives. These latter could act as substrate analogue of L-tyrosine and inhibit the monophenolase activity of the enzyme by a competitive mechanism.
Finally, compounds 2 and 12, the lead compounds of this study, have an inhibitory effect comparable to that of hydroquinone, one of the reference products in matter of depigmenting agents but with some adverse effects. Thus, our study qualifies the compounds 2 and 12 for further investigations on cellular and animal models to evaluate their effect on melanin formation and skin pigmentation and to determine their safety profile.
